http://rdf.ncbi.nlm.nih.gov/pubchem/reference/4616708

Outgoing Links

Predicate Object
contentType Journal Article
endingPage 118
issn 0939-6411
pageRange 108-118
publicationName European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
startingPage 108
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a1ebfe17b0713ecaf89801f0370c078d
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a500274ddff6e3ece320321eaa155c72
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_36b8bba3e5bca5b3ff5cc1c47f0eb6bc
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_8c552d0a3e0057ff5996e6e25f1cf6f8
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_2564035c971d56f16324e1cf7d88fdea
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_e721e02d016e6113c317061b937dd964
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_96399cf467d751009df55ca07098ae89
bibliographicCitation Powell D, Chandra S, Dodson K, Shaheen F, Wiltz K, Ireland S, Syed M, Dash S, Wiese T, Mandal T, Kundu A. Aptamer-functionalized hybrid nanoparticle for the treatment of breast cancer. European Journal of Pharmaceutics and Biopharmaceutics. 2017 May;114():108–18. doi: 10.1016/j.ejpb.2017.01.011.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3c7e1e5eae9f85e738e7cf2b7a2e1231
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1ff4dc64a764589e27a6a2a408d4add3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c7f972fcbbdf59c2687cbcfb0f82aa5f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fb5d5067063be3a23005b643cd3f7aa1
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3820994679b359e92472ccd2a5f08e43
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ee55a38906eef216bb32bd8f2b63063e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_05fa918924bac880f0b71f9748dd3c10
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_46976c044cc5bf28170a1ee265c9a943
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_06366a3ee53b721445b2f4f001287cdc
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fbe77d6b60cc17f987e4228339a4b53e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4916c758922a0756618c81b5afcc2bc9
date 201705
identifier https://pubmed.ncbi.nlm.nih.gov/28131717
https://pubmed.ncbi.nlm.nih.gov/PMC5373964
https://doi.org/10.1016/j.ejpb.2017.01.011
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21026
https://portal.issn.org/resource/ISSN/0939-6411
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Aptamer-functionalized hybrid nanoparticle for the treatment of breast cancer
discusses http://id.nlm.nih.gov/mesh/M0483498
http://id.nlm.nih.gov/mesh/M0001483
http://id.nlm.nih.gov/mesh/M0012600
http://id.nlm.nih.gov/mesh/M0028048
http://id.nlm.nih.gov/mesh/M0495206
http://id.nlm.nih.gov/mesh/M0007997
http://id.nlm.nih.gov/mesh/M0406100
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D000970Q000627
http://id.nlm.nih.gov/mesh/D000970Q000008
http://id.nlm.nih.gov/mesh/D053758Q000737
http://id.nlm.nih.gov/mesh/D034741Q000008
http://id.nlm.nih.gov/mesh/D052157Q000737
http://id.nlm.nih.gov/mesh/D034741Q000627
http://id.nlm.nih.gov/mesh/D001943Q000188
hasSubjectTerm http://id.nlm.nih.gov/mesh/D045744
http://id.nlm.nih.gov/mesh/D010316
http://id.nlm.nih.gov/mesh/D008081
http://id.nlm.nih.gov/mesh/D020868
http://id.nlm.nih.gov/mesh/D018719Q000378
http://id.nlm.nih.gov/mesh/D061986
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D016503
http://id.nlm.nih.gov/mesh/D005079
http://id.nlm.nih.gov/mesh/D005260
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10935
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31703
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID447078
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5997
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_2b41adbd094947475b63355088c8b2f4
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6437371
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_43830973f74de180729ad1e755d592ad
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16218742
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18730
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_f9824ba4a0c1053d3c448d752236fe4f
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_6bd0a2e7e4915fc67c2e7270a895cdae
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1117
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11636182
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15061530

Total number of triples: 77.